Norinchukin Bank, The Vertex Pharmaceuticals Inc Transaction History

Norinchukin Bank, The

$3.46 Billion
Q2 2024

A detailed history of Norinchukin Bank, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Norinchukin Bank, The holds 11,135 shares of VRTX stock, worth $5.05 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

11,135

Previous 11,130 0.04%

Holding current value

$5.05 Million

Previous $4.65 Million 12.19%

% of portfolio

0.15%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1,964 - $2,427	5 Added 0.04%	11,135 $5.22 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $96,622 - $105,720	-237 Reduced 2.08%	11,130 $4.65 Million
Q4 2023 Feb 13, 2024	SELL	$343.0 - $410.68 $569,037 - $681,318	-1,659 Reduced 12.74%	11,367 $4.63 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $4.41 Million - $4.72 Million	13,026 New	13,026 $4.53 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.08 Million - $2.33 Million	6,622 Added 32.77%	26,829 $9.44 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $147,846 - $168,658	522 Added 2.65%	20,207 $6.37 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $1.25 Million - $1.41 Million	-4,391 Reduced 18.24%	19,685 $5.68 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $667,597 - $744,882	2,438 Added 11.27%	24,076 $6.97 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $1.11 Million - $1.38 Million	-4,719 Reduced 17.9%	21,638 $6.1 Million
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $549,564 - $647,727	2,482 Added 10.4%	26,357 $6.88 Million
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $339,682 - $428,800	-1,919 Reduced 7.44%	23,875 $5.24 Million
Q3 2021 Nov 09, 2021	BUY	$181.39 - $202.99 $253,764 - $283,983	1,399 Added 5.73%	25,794 $4.68 Million
Q2 2021 Aug 11, 2021	BUY	$187.49 - $221.1 $40,685 - $47,978	217 Added 0.9%	24,395 $4.92 Million
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $234,967 - $273,886	1,135 Added 4.93%	24,178 $5.2 Million
Q4 2020 Feb 12, 2021	SELL	$207.01 - $276.09 $27,325 - $36,443	-132 Reduced 0.57%	23,043 $5.45 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $198,895 - $235,811	778 Added 3.47%	23,175 $6.31 Million
Q2 2020 Aug 12, 2020	BUY	$225.48 - $295.8 $2,029 - $2,662	9 Added 0.04%	22,397 $6.5 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $2.48 Million - $3.08 Million	-12,421 Reduced 35.68%	22,388 $5.33 Million
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $501,463 - $673,521	-3,008 Reduced 7.95%	34,809 $7.62 Million
Q3 2019 Nov 12, 2019	BUY	$166.23 - $187.09 $166,894 - $187,838	1,004 Added 2.73%	37,817 $6.41 Million
Q2 2019 Aug 09, 2019	SELL	$164.61 - $190.37 $2.05 Million - $2.37 Million	-12,442 Reduced 25.26%	36,813 $6.75 Million
Q1 2019 May 10, 2019	BUY	$163.73 - $194.7 $282,597 - $336,052	1,726 Added 3.63%	49,255 $9.06 Million
Q4 2018 Feb 08, 2019	BUY	$151.91 - $192.21 $2.23 Million - $2.82 Million	14,658 Added 44.59%	47,529 $7.88 Million
Q3 2018 Nov 08, 2018	BUY	$167.73 - $192.74 $670,584 - $770,574	3,998 Added 13.85%	32,871 $6.34 Million
Q2 2018 Aug 10, 2018	BUY	$145.72 - $169.96 $817,197 - $953,135	5,608 Added 24.1%	28,873 $4.91 Million
Q1 2018 May 10, 2018	BUY	$151.6 - $177.13 $461,773 - $539,537	3,046 Added 15.07%	23,265 $3.79 Million
Q4 2017 Feb 09, 2018	BUY	$137.28 - $155.55 $199,605 - $226,169	1,454 Added 7.75%	20,219 $3.03 Million
Q3 2017 Nov 08, 2017	BUY	$148.13 - $162.24 $2.78 Million - $3.04 Million	18,765	18,765 $2.85 Million

Others Institutions Holding VRTX

# of Institutions

1,708

Shares Held

225M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norinchukin Bank, The, based on Form 13F filings with the SEC.

News

Stay updated on Norinchukin Bank, The with notifications on news.

Account

Norinchukin Bank, The Vertex Pharmaceuticals Inc Transaction History